Use of the molecular adsorbent recirculating system in acute liver failure: a North American multicenter experience

2020 ◽  
Vol 73 ◽  
pp. S218-S219
Author(s):  
Andrew MacDonald ◽  
Ram Subramanian ◽  
Jody Olson ◽  
Brianne Shropshire ◽  
Ravi Vora ◽  
...  
2006 ◽  
Vol 32 (11) ◽  
pp. 1817-1825 ◽  
Author(s):  
Christophe Camus ◽  
Sylvain Lavoué ◽  
Arnaud Gacouin ◽  
Yves Le Tulzo ◽  
Richard Lorho ◽  
...  

2002 ◽  
Vol 22 ◽  
pp. 43-47 ◽  
Author(s):  
G Novelli ◽  
M Rossi ◽  
R Pretagostini ◽  
L Poli ◽  
L Novelli ◽  
...  

2008 ◽  
Vol 40 (6) ◽  
pp. 1921-1924 ◽  
Author(s):  
G. Novelli ◽  
M. Rossi ◽  
V. Morabito ◽  
F. Pugliese ◽  
F. Ruberto ◽  
...  

Critical Care ◽  
2010 ◽  
Vol 14 (Suppl 1) ◽  
pp. P539
Author(s):  
D Tran-Zweifel ◽  
B Goubaux ◽  
L Bornard ◽  
J Dellamonica ◽  
M Carles ◽  
...  

2003 ◽  
Vol 35 (2) ◽  
pp. 822-823 ◽  
Author(s):  
M Felldin ◽  
S Friman ◽  
L Backman ◽  
A Siewert-Delle ◽  
B.-Å Henriksson ◽  
...  

2018 ◽  
Vol 19 (2) ◽  
pp. 189-194
Author(s):  
Jagoda Gavrilovic ◽  
Jelena Djordjevic Velickovic ◽  
Zeljko Mijailovic ◽  
Tatjana Lazarevic ◽  
Aleksandar Gavrilovic ◽  
...  

Abstract Acute liver failure (ALF) is a rare but life-threatening illness with multiple organ failure. The short-term mortality rate exceeded 80 % despite modern approaches in treatment. Drugs, infections by hepatic viruses and toxins are the most common causes of ALF. Progressive jaundice, coagulation disorder and hepatic encephalopathy are dominated as a clinical signs of the illness. We present a case of a 36-year-old Caucasian woman hospitalized in ICU due to yellow discoloration of the skin and sclera, severe disseminated coagulopathy and hemodynamic instability. ALF is developed due to Hepatitis B Virus infection, resulting in hepatic toxicity as well as coma. General condition rapidly improved after applying of Molecular Adsorbent Recirculating System (MARS), an extracorporeal liver support system based on albumin dialysis. It is relatively expensive treatment that is used for the patient with hepatic encephalopathy grade 3 or 4 in our institution. In conclusion, an early administration of MARS significantly reveals subjective and objective clinical improvement in the case we presented.


Sign in / Sign up

Export Citation Format

Share Document